Barclays raised the firm’s price target on Ovintiv (OVV) to $58 from $55 and keeps an Overweight rating on the shares following the Q4 beat.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv price target raised to $50 from $42 at Roth Capital
- Ovintiv: Portfolio Reshaping and Capital Efficiency Drive Buy Rating and Re‑Rating Potential
- Ovintiv: Strong 4Q25 Beat, Stable 2026 Outlook, and Enhanced Capital Returns Drive Buy Rating
- Ovintiv Announces Enhanced 2026 Shareholder Return Framework
- Ovintiv reports Q4 EPS $3.70, consensus $1.01